Pennsylvania 2025_0 Regular Session Status: In Committee Bipartisan · 29 D · 7 R cosponsors

HB 2041 — An Act amending the act of November 3, 2022 (P.L.2135, No.150), known as the Childhood Blood Lead Test Act, further providing for title of act, for legislative purpose, for definitions, for lead poisoning prevention, assessment and testing, for duties of department and for blood lead assessment and testing coverage.

Last action — Referred to CHILDREN AND YOUTH, Nov. 17, 2025

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced November 17, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

Prognosis

Advancing 42% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • In Committee

    Current position in the legislative process.

  • 36 sponsors

    1 primary, 35 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (29 D · 7 R) — cross-party backing.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

Child Lead Testing

Bill Text

How this bill changes current law

7 changes Share ↗

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

The bill strengthens testing requirements for lead exposure in children and pregnant women and mandates insurance coverage for such tests without cost-sharing.

  • Section 1

    providers → practitioners

    Changes the term 'providers' to 'practitioners'.

  • Section 3(3)

    encourage → require

    Changes the language from encouraging to requiring lead testing for children by two years of age.

  • Section 5(a)

    Lead testing for children.-- (1) The following apply: (i) A health care provider shall consider possible lead exposure in an individual patient by evaluating risk factors for lead exposure and perform blood lead testing in accordance with recommendations from the Centers for Disease Control and Prevention and the American Academy of Pediatrics by 24 months of age. (ii) If a patient has never been tested in accordance with recommendations from the Centers for Disease Control and Prevention and the American Academy of Pediatrics by 24 months of age, a health care provider shall consider possible lead exposure and perform blood lead testing in an individual patient between 24 months and 72 months of age. (iii) A health care provider shall make reasonable efforts to ensure that a patient's parent or legal guardian understands the risks and benefits of blood lead testing prior to obtaining consent. (2) If a patient's parent or legal guardian consents to blood lead testing for the patient under paragraph (1) and the results of a capillary blood lead test indicate an elevated blood lead level, the health care provider shall perform a confirmatory blood lead test by venipuncture within 12 weeks of the first blood lead test after obtaining the consent of the patient's parent or legal guardian. → Lead testing requirements for children.-- (1) A health care practitioner shall make reasonable efforts to ensure that a patient under the health care practitioner's care receives at least one blood lead test by 12 months of age and a second blood lead test by 24 months of age. (2) If a patient has never been tested by 24 months of age, a health care practitioner shall ensure that the patient receives at least one blood lead test between 24 months and 72 months of age. (3) If a capillary blood lead test indicates an elevated blood lead level, a health care practitioner shall perform a confirmatory blood lead test by venipuncture in accordance with recommendations from the Centers for Disease Control and Prevention.

    Replaces previous lead testing procedures for children with stricter requirements for testing at specified ages.

  • Section 5(b)

    provider → practitioner

    Changes the term 'provider' to 'practitioner' in relation to lead exposure assessment for pregnant women.

  • Section 7(a)(1)

    one blood lead test per pregnancy [if a single risk factor is identified in accordance with recommendations from the Centers for Disease Control and Prevention and the American College of Obstetricians and Gynecologists] → one blood lead test per pregnancy

    Clarifies that one blood lead test is required per pregnancy without the conditionality on risk factors.

  • Section 7(a)(2)(i)

    at least [one blood lead test] two blood lead tests by 24 months of age → at least two blood lead tests by 24 months of age

    Mandates a total of two blood lead tests for children under two years of age instead of at least one.

  • Section 7(b)

    Coverage under this section shall be subject to copayment, deductible and coinsurance provisions and any other general exclusions or limitations of a health insurance policy or government program to the same extent as other medical services covered by the policy or program are subject to these provisions. → A blood lead test covered under subsection (a) shall not be subject to cost-sharing.

    Eliminates cost-sharing for blood lead tests, ensuring there's no out-of-pocket expense for patients.

Action History

  1. Referred to CHILDREN AND YOUTH, Nov. 17, 2025

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 35 co-sponsors · 217 not signed on

Sponsors (1)

Co-sponsors (35)

Not signed on (217)

217 members have not signed on to this bill.

Show all 217 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 2041 do?
Child Lead Testing
Who sponsors HB 2041?
HB 2041 is sponsored by Shelby Labs (Republican), Nikki Rivera (Democratic), Ben Waxman (Democratic), Jeanne McNeill (Democratic), Joseph C. Hohenstein (Democratic), Liz Hanbidge (Democratic), Mark M. Gillen (Republican), Gina H. Curry (Democratic), Dave Madsen (Democratic), Mike Armanini (Republican), Eddie Day Pashinski (Democratic), Lindsay Powell (Democratic), Nancy Guenst (Democratic), Lisa A. Borowski (Democratic), Elizabeth Fiedler (Democratic), Ed Neilson (Democratic), Greg Scott (Democratic), Kristin Marcell (Republican), Tim Briggs (Democratic), Joe Ciresi (Democratic), Abigail Salisbury (Democratic), Tarik Khan (Democratic), Ismail Smith-Wade-El (Democratic), G. Roni Green (Democratic), MaryLouise Isaacson (Democratic), Heather Boyd (Democratic), Joe Hogan (Republican), Natalie Mihalek (Republican), Benjamin V. Sanchez (Democratic), Dan K. Williams (Democratic), Jose Giral (Democratic), R. Lee James (Republican), Mary Jo Daley (Democratic), Dan Frankel (Democratic), Rick Krajewski (Democratic), and Jim Prokopiak (Democratic).
What is the current status of HB 2041?
This bill is in committee in the House. Introduced November 17, 2025. It must pass committee before a floor vote.
Where can I track HB 2041?
Track HB 2041 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 2041

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HB 2041

Last checked for changes 4 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →